APOA1 and coronary artery disorder: Furthermore, recent Mendelian randomization analyses have shown that circulating apoA‐I concentrations are unlikely to be causally related to CHD [8, 17], providing indirect evidence that therapeutic modification of HDL‐CEC may not be beneficial.